Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Balchem Corp. (BCPC) Management Steadily Strengthens Profitable Shares of Growing Markets

This company seems set to improve its returns on average equity during the full 2007 year, compared to the 18.02% achieved in 2006. The corresponding figure at the quarter ended September 2007 is 20.5%. Investors will glean, from a qualitative review of the company’s business, that the management has developed multiple growth options for the future.

The company operates in so many business segments that a cursory view could lead stock investors to suspect that the management lacks focus. However, the secret of success seems to be that each business line operates as an integral subsidiary. The demarcation of corporate strategy from daily operations allows the company to do business in ranges from Over-the-Counter (OTC) medicines for osteoporosis, to sophisticated sterilization gases for medical devices. The company also has a broad range of brands for cattle, poultry, and human nutrition.

2008 seems to be a great time to watch this stock because the company has a choline business throughout the world, and has also acquired business facilities in Italy. Stock fortunes will not depend overly on the US dollar, in this case The world-wide spread of revenues blends very well with the broad array of business segments in which the company is present to protect stock value in most likely business scenarios. Choline and chelation are two areas in which the management has built competitive advantages, and these strengths are versatile, with multiple options for continued business leverage. The management also displays a heartening level of customer integration, as for example, in presenting the sterilization gases in sizes and forms to fit the needs of diverse customers.

Overall, this stock is a tranquil and reliable harbor in the current stock market conditions of volatility.

Let us hear your thoughts below:  

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *